1. Home
  2. CYTK vs AVAV Comparison

CYTK vs AVAV Comparison

Compare CYTK & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • AVAV
  • Stock Information
  • Founded
  • CYTK 1997
  • AVAV 1971
  • Country
  • CYTK United States
  • AVAV United States
  • Employees
  • CYTK N/A
  • AVAV N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • AVAV Aerospace
  • Sector
  • CYTK Health Care
  • AVAV Industrials
  • Exchange
  • CYTK Nasdaq
  • AVAV Nasdaq
  • Market Cap
  • CYTK 6.0B
  • AVAV 5.6B
  • IPO Year
  • CYTK 2004
  • AVAV 2007
  • Fundamental
  • Price
  • CYTK $49.10
  • AVAV $195.91
  • Analyst Decision
  • CYTK Buy
  • AVAV Buy
  • Analyst Count
  • CYTK 16
  • AVAV 6
  • Target Price
  • CYTK $83.67
  • AVAV $225.20
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • AVAV 364.2K
  • Earning Date
  • CYTK 11-06-2024
  • AVAV 12-04-2024
  • Dividend Yield
  • CYTK N/A
  • AVAV N/A
  • EPS Growth
  • CYTK N/A
  • AVAV N/A
  • EPS
  • CYTK N/A
  • AVAV 2.11
  • Revenue
  • CYTK $3,219,000.00
  • AVAV $753,856,000.00
  • Revenue This Year
  • CYTK N/A
  • AVAV $18.14
  • Revenue Next Year
  • CYTK $911.39
  • AVAV $15.26
  • P/E Ratio
  • CYTK N/A
  • AVAV $92.81
  • Revenue Growth
  • CYTK N/A
  • AVAV 29.00
  • 52 Week Low
  • CYTK $30.68
  • AVAV $116.51
  • 52 Week High
  • CYTK $110.25
  • AVAV $236.60
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 39.46
  • AVAV 38.76
  • Support Level
  • CYTK $49.64
  • AVAV $189.26
  • Resistance Level
  • CYTK $59.39
  • AVAV $205.05
  • Average True Range (ATR)
  • CYTK 2.46
  • AVAV 11.41
  • MACD
  • CYTK -0.69
  • AVAV -3.38
  • Stochastic Oscillator
  • CYTK 14.11
  • AVAV 14.05

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AVAV AeroVironment Inc.

AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.

Share on Social Networks: